login

The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation

Journal of NeuroinflammationPublished 12 July 2018Open access
Zengli Zhang, Pei Qin, Youliang Deng, Zhi Ma, Hang Guo, Haiyun Guo
Citations197
SJR quartileQ1
SJR score3.18
SNIP1.99
View PDF

TL;DR

Microglial G PR30 exerts acute neuroprotective effects by inhibiting TLR4-mediated microglial inflammation, which indicates that GPR30 may be a potential target for the treatment of ischemic stroke.

Abstract

Microglial GPR30 exerts acute neuroprotective effects by inhibiting TLR4-mediated microglial inflammation, which indicates that GPR30 may be a potential target for the treatment of ischemic stroke.

Keywords

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology